Dr. Daniel Robert Lefebvre, MD

Dr. Lefebvre practices at Lexington Eye Associates, Inc in Dedham, Massachusetts.

Dr. Lefebvre's NPI, 1013163567, was assigned on August 15, 2008. Dr. Lefebvre graduated from State University of NY Upstate Medical University in 2005. Dr. Lefebvre holds Massachusetts license 242588.

Dr. Lefebvre's primary practice is Lexington Eye Associates, Inc, at 980 Washington St, Dedham, MA 02026 in Norfolk County. The practice phone is (781) 862-1620.

Dr. Lefebvre's primary practice is Lexington Eye Associates, Inc in Dedham, Massachusetts. Dr. Lefebvre is also affiliated with Massachusetts Eye and Ear. Dmand AI also links Dr. Lefebvre to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lefebvre practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Lefebvre's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Lefebvre is licensed in Massachusetts.

CMS data shows 351 Medicare services from Dr. Lefebvre across 8 procedure codes in 2024, for 147 Medicare patients. Medicare paid $37,126 for them. Every service was in an office.

CMS counts 147 Medicare patients who saw Dr. Lefebvre in 2024. The largest group is 75 to 84, with 58 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lefebvre's median patient age at 70, with 66% women.

In 2024, Dr. Lefebvre wrote 124 Medicare Part D claims for 64 patients. 91% of them were for generic drugs. CMS names the drug for 78 of them, across 3 drugs with 11 or more claims each, at $1,316 in total drug cost. In 2023, CMS named 41 claims across 1 drug.

CMS lists Dr. Lefebvre as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 57 papers to Dr. Lefebvre, published from 2012 to 2025. 2016 was the busiest year, with 4. The most frequent topics are Orbit, Endoscopy and Tomography, X-Ray Computed. Dr. Lefebvre has published most often in Ophthalmic Plast Reconstr Surg. Dr. Lefebvre's most frequent co-authors are Suzanne K. Freitag, MD, Nahyoung Grace Lee, MD and Benjamin Saul Bleier, MD.

Dmand AI links Dr. Lefebvre to 1 clinical trial. Conditions studied include Graves Ophthalmopathy and Exophthalmos.

CMS Open Payments shows 4 general payments to Dr. Lefebvre from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Horizon Pharma plc paid the most, $172.

Dr. Lefebvre graduated from State University of NY Upstate Medical University in 2005.